Numerof & Associates December 7, 2021
As our Numerof 2022 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value while dealing with the aftereffects of the pandemic.
Across the globe, engagement with stakeholders will require new approaches as systems and practices continue to limit representative access in some therapeutic areas. This will force continued innovation – not just in your engagement efforts, but organizationally, in the way you structure and support your commercial approach. The need for new and different ways to engage with healthcare executives, physicians, and payers will not be going away anytime soon.
Ongoing efforts to accelerate drug development mean companies may face competition more quickly than...
Today's Sponsors
Today's Sponsor